Reckitt Benckiser (Bangladesh) PLC (DSE:RECKITTBEN)

Market Cap	16.01B
Revenue (ttm)	5.59B
Net Income (ttm)	751.81M
Shares Out	4.73M
EPS (ttm)	159.11
PE Ratio	21.30
Forward PE	n/a
Dividend	333.00 (9.67%)
Ex-Dividend Date	Apr 30, 2025

Volume	5,981
Average Volume	4,884
Open	3,455.00
Previous Close	3,444.50
Day's Range	3,376.00 - 3,455.00
52-Week Range	3,159.50 - 5,012.70
Beta	0.05
RSI	50.66
Earnings Date	Aug 10, 2025

About Revance Therapeutics

Reckitt Benckiser (Bangladesh) PLC manufactures and markets household, toiletry, and pharmaceutical products in Bangladesh. The company sells its products under the Harpic, Dettol, Lysol, Trix, Vanish, Veet, Mortein, Mr. Brasso, Mucinex, Nurofen, Gaviscon, Strepsils, Finish, and Durex brand names. The company was formerly known as Reckitt & Colman Bangladesh Limited and changed its name to Reckitt Benckiser (Bangladesh) PLC in November 2000. The company was founded in 1938 and is based in Dhaka, Bangladesh. Reckitt Benckiser (Bangladesh) PLC op...

• Industry: Soap, Detergents, And Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 1938
• Employees: 332
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: RECKITTBEN

Financial Performance

In 2024, DSE:RECKITTBEN's revenue was 5.46 billion, an increase of 3.36% compared to the previous year's 5.28 billion. Earnings were 752.08 million, a decrease of -8.34%.